TRN
KMB

Todd MacLin

Known title: DirectorCIK: 0001775725

Todd MacLin's purchase track record

How the stock did after each of Todd MacLin's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 4 since January 27, 2022
Stock higher 6 months later
50%
3 months: 50%
Median 6-month return
+2.3%
3 months: +1.2%
Beat the S&P 500
25%
median -3.9% vs. index
PurchaseStockAmount3 months6 months
2/9/2026KMB$1.04M-7.4%+5.9%
4/9/2025KMB$39K-1.8%-9.8%
3/17/2023TRN$95K+9.5%+11.2%
1/27/2022KMB$272K+4.2%-1.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

TRN highlighted in SeekingAlpha dividend champion roundup. SeekingAlpha included Trinity Industries in its Week of October 11 dividend champion, contender and challenger highlights. The mention underscores the company's 4.20% dividend yield and low trailing P/E of 6.1, traits often noted by dividend‑focused analysts. This coverage may draw attention from investors who prioritize income and valuation metrics.

this person other insiders at TRN

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Kimberly-Clark Guidance Reiterated as Sales Slip, Bond Sale Planned. Kimberly‑Clark confirmed its full‑year guidance even though recent sales were weaker than expected, which analysts at UBS said could help keep the stock stable. The company is also preparing a bond issuance to fund its planned purchase of a Tylenol‑making business. Shares have fallen about 13% and are trading near a long‑standing support level, while the dividend growth streak faces pressure. The mixed performance of consumer stocks and the stock’s inclusion in dividend‑focused lists add further context.

this person other insiders at KMB

Transaction History

TRN▲ Buy$0
KMB▲ Buy$1.0M
KMB▲ Buy$39K
KMB▼ Sell$0
TRN▲ Buy$95K
TRN▲ Buy$0
KMB▲ Buy$272K

We use analytics to understand how market-wall is used. No personal data is sold.